| Literature DB >> 21731555 |
Steven W Hutcheson1, Haitao Zhang1,2, Maxim Suvorov2.
Abstract
Saccharophagus degradans 2-40 is a γ-subgroup proteobacterium capable of using many of the complex polysaccharides found in the marine environment for growth. To utilize these complex polysaccharides, this bacterium produces a plethora of carbohydrases dedicated to the processing of a carbohydrate class. Aiding in the identification of the contributing genes and enzymes is the known genome sequence for this bacterium. This review catalogs the genes and enzymes of the S. degradans genome that are likely to function in the systems for the utilization of agar, alginate, α- and β-glucans, chitin, mannans, pectins, and xylans and discusses the cell biology and genetics of each system as it functions to transfer carbon back to the bacterium.Entities:
Keywords: agarase; alginase; amylase; chitinase; glucanase; mannanase; pectinase; xylanase
Mesh:
Substances:
Year: 2011 PMID: 21731555 PMCID: PMC3124978 DOI: 10.3390/md9040645
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
The agarolytic system of S. degradans.
| Aga16B | 1175 | + | GH16 | 6 (×2) | 64.5 | endoagarase | + |
| Aga50D | 2644 | + | GH50 | 88.6 | exoagarase | + | |
| Aga86E | 2655 | + | GH86 | 6 (×3) | 146.2 | exoagarase | + |
| Aga50A | 1176 | Lipobox | GH50 | 87.4 | likely exoagarase | + | |
| Aga86C | 2650 | Lipobox | GH86 | 86.2 | endoagarase | + | |
| AgaT | 2649 | Inner membrane | putative transporter | ||||
| Aga117F | 2657 | - | GH117 | 41.6 | neoagarobiose hydrolase | + |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox as detected by LipoP 1.0 server;
as determined by CAZY [11]; GH, Glycoside hydrolase; CBM, carbohydrate binding domain;
As described by [18];
from [15];
from [16];
from [19];
as described in [17].
The predicted alginolytic system of S. degradans.
| Alg2A | 3278 | + | PL2 | 16, FA58C | 58.5 | alginate lyase |
| Alg6B | 3285 | + | PL6 | 83.2 | same | |
| Alg17C | 3284 | + | PL7 | 81.6 | same | |
| Alg7D | 2547 | + | PL7 | 32, FA58C | 65.4 | same |
| Alg6F | 2873 | + | PL6 | 163.1 | same | |
| Alg7G | 1507 | + | PL7 | 32, FA58C | 94.3 | same |
| Alg18J | 3272 | + | PL18 | 16, 32 | 58.5 | same |
| Alg14M | 3918 | + | PL14 | 44.2 | same | |
| Alg7A | 3286 | Lipobox | PL7 | 37.5 | same | |
| Alg7E | 2478 | Lipobox | PL7 | 32, FA58C | 56.3 | same |
| Alg6H | 3275 | Lipobox | PL6 | 93.6 | same | |
| Alg6I | 3274 | Lipobox | PL6 | 57.4 | same | |
| Alg7K | 2839 | Lipobox | PL7 | 50.5 | same | |
| DctM | 1268 | Inner membrane | transporter | |||
| DctQ | 1267 | Inner membrane | transporter | |||
| DctP | 1266 | Periplasm | transporter | |||
| HxuI | 950 | - | 4-deoxy- | |||
| HxuK | 1280 | - | same | |||
| 1269 | - | 2-dehydro-3-deoxygluconate kinase | ||||
| HxuA | 1382 | - | 2-dehydro-3-deoxyphosphogluconate aldolase | |||
| AlgR | 1270 | - | GntR family regulator |
As described in [10] or here;
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by CAZY [11]; PL, polysaccharide lyase domain.
The predicted α-glucan degradation system of S. degradans.
| Amy13A | 556 | + | GH13 | 70.1 | α-amylase | |
| Amy13B | 563 | + | GH13 | 81.6 | α-amylase | |
| Amy13C | 573 | + | GH13 | 64.6 | α-amylase | |
| Gly97A | 590 | + | GH97 | 76.6 | α-glucosidase | |
| Gly97D | 2360 | + | GH97 | 76.4 | α-glucosidase | |
| Gly97B | 2499 | + | GH97 | 77.0 | α-glucosidase | |
| Cbm20A | 314 | + | 20 | 71.0 | Starch binding | |
| PulA | 560 | Lipobox | pul | 151.3 | pullananase | |
| PulB | 589 | Lipobox | 77.1 | pullananase helper | ||
| Amy13D | 2938 | Lipobox | GH13 | 20 | 37.5 | α-amylase |
| GlyNAX | 600 | Lipobox | 87.4 | glucan 1,4-α-glucosidase | ||
| GlgT | 1017 | Inner membrane | Glc/Gal transporter | |||
| GlkA | 1018 | - | glucose kinase | |||
| Gly13E | 601 | - | GH13 | 61.3 | α-glucosidase | |
| Suc13F | 3210 | - | GH13 | 68.3 | sucrose phosphorylase |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by CAZY [11].
The cellulolytic system of S. degradans.
| Cel5A | 3003 | + | GH5 (×2) | 6 (×3) | 127.2 | endoglucanase | + |
| Cel5D | 2636 | + | GH5 | 2a, 10 | 65.9 | endoglucanase | + |
| Cel5E | 2929 | + | GH5 | 6 (×2) | 65.4 | endoglucanase | + |
| Cel5F | 1572 | + | GH5 | 42.0 | endoglucanase | + | |
| Cel5G | 3239 | + | GH5 | 6 | 67.9 | endoglucanase | + |
| Cel5H | 3237 | + | GH5 | 6 | 66.9 | endoglucanase | + |
| Cel5I | 3420 | + | GH5 | 2a, 10 | 77.2 | endoglucanase | + |
| Cel5J | 2494 | + | GH5 | 6 (×2) | 65.2 | endoglucanase | + |
| Cel6A | 2272 | + | GH6 | 2 (×2) | 81.2 | endoglucanase | + |
| Cel9A | 636 | + | GH9 | 62.7 | endoglucanase | + | |
| Cel9B | 649 | + | GH9 | 2a, 10 | 89.5 | endoglucanase | + |
| Cel5B | 2490 | Lipobox | GH5 | 6 | 60.8 | endoglucanase | + |
| Cel5C | 0325 | Lipobox | GH5 | 49.1 | endoglucanase | + | |
| Gly5L | 2996 | Lipobox | GH5 | 6 | 93.3 | endoglucanase | + |
| Gly5M | 3023 | Lipobox | GH5 | 6 | 94.9 | endoglucanase | + |
| Ced3A | 2497 | Lipobox | GH3 | 116.0 | β-glucosidase | + | |
| Ced3B | 0245 | Lipobox | GH3 | 92.9 | β-glucosidase | + | |
| Bgl3C | 2674 | Lipobox | GH3 | 95.4 | β-glucosidase | + | |
| Bgl1A | 3603 | - | GH1 | 52.8 | β-glucosidase | + | |
| Bgl1B | 1394 | - | GH1 | 49.8 | β-glucosidase | + | |
| Cep94A | 1318 | - | GH94 | 91.7 | cellobiose phosphorolase | + |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by the CAZY team [11];
see [38–40];
see [41].
The chitinolytic system of S. degradans.
| Chi18A | 1704 | + | GH18 | 5 | 56.3 | endochitinase | + |
| Chi18C | 3605 | + | GH18 | 5 | 82.5 | endochitinase | + |
| Cdx18A | 3902 | + | GH18 | 5 | 122.1 | chitodextrinase | + |
| CbpA | 633 | + | 2, 33 | 46.1 | chitin binding | ||
| Chi18B | 3870 | Lipobox | GH18 (×2) | 135.2 | endo/exochitinase | + | |
| Hex20A | 3037 | Lipobox | GH20 | FA58C | 88.5 | + | |
| Hex20B | 3271 | Periplasm | GH20 | FA58C | 98.4 | + | |
| NagE | 3038 | Inner membrane | 47.5 | NAG transporter | |||
| Hex3C | 1790 | - | GH3 | 37.5 | + | ||
| NagF | 3036 | - | 31.8 | ||||
| NagC | 3047 | - | 41.4 | LacI homolog | |||
| NagB | 3041 | - | 37.0 | fructose 6P transaminase | |||
| NagA | 3040 | - | 41.4 |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by CAZY [11];
As described in [41];
As described in [47].
The predicted laminarinase system of S. degradans.
| Lam16A | 1393 | + | GH16 | 6 (×2), 56 | 183.2 | β-1,3(4)-endoglucanase |
| Lam16B | 2927 | + | GH16 | 6, FA58C (×2) | 158.6 | β-1,3(4)-endoglucanase |
| Lam16C | 1444 | + | GH16 | 4, 32 | 129.1 | β-1,3(4)-endoglucanase |
| Lam16D | 3021 | + | FA58C | 77.7 | β-1,3(4)-endoglucanase | |
| Lam16E | 0652 | + | GH16 | 6 (×2) | 61.4 | β-1,3(4)-endoglucanase |
| Gly16H | 2878 | + | GH16 | 32, FA58C | 107.2 | β-1,3(4)-endoglucanase |
| Lam16F | 3141 | Lipobox | GH16 | 80.2 | β-1,3(4)-endoglucanase | |
| Lam16G | 2832 | Lipobox | GH16 | 6 (×2) | 94.2 | β-1,3(4)-endoglucanase |
| Lam81A | 2834 | Lipobox | GH16 | 56 | 133.1 | β-1,3-endoglucanase |
| Gly30A | 2992 | Lipobox | GH30 | 6 (×2), 13 | 107.4 | β-1,6-glucosidase |
| Gly30B | 2994 | Lipobox | GH30 | 52.8 | β-1,6-glucosidase | |
| Lam55A | 54 | - | GH55 | FA58C | 58.5 | β-1,3-endo/exoglucanase |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by CAZY [11].
The predicted mannanase system of S. degradans.
| Man5O | 656 | + | GH5 | 10 | 52.6 | mannanase |
| Man5N | 64 | + | GH5 | 2, 10 | 57.6 | mannosidase |
| Gly5K | 2993 | + | GH5 | 6 (×2), 13 | 94.6 | |
| Man5P | 509 | Lipobox | GH5 | 50.9 | mannanase | |
| ManR | 2285 | Lipobox | 42.8 | mannanase | ||
| Man5Q | 2541 | Lipobox | GH5 | 92.3 | mannanase | |
| Man26A | 3691 | Lipobox | GH26 | 10, cbm | 54.9 | mannosidase |
| Man2A | 169 | - | GH2 | 91.7 | mannosidase | |
| Man2B (Gly5R) | 1121 | - | GH2 | 59.2 | mannanase |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by CAZY [11];
not currently classified CBM.
The probable pectinase system of S. degradans.
| Pel1B | 937 | + | PL1 | 46.1 | pectate lyase | |
| Pel1C | 942 | + | PL1 | 6, 35 | 78.9 | pectate lyase |
| Pel1A | 943 | + | PL1 | 6, 35 | 136.4 | pectate lyase |
| Pel1F | 2311 | + | PL1 | 2, 6, 35 | 81.5 | pectate lyase |
| Pel3B | 608 | + | PL3 | 46.1 | pectate lyase | |
| Pel3D | 1703 | + | PL3 | 13 | 41.6 | pectate lyase |
| Pel3A | 2308 | + | PL3 | 2, 6 | 52.3 | pectate lyase |
| Pel3C | 3007 | + | PL3 | 42.9 | pectate lyase | |
| Pel10A | 1051 | + | PL10 | 2, 6, 35 | 73.3 | pectate lyase |
| Pel11A | 1650 | + | PL11 | 35 | 97.6 | rhamnogalacturon lyase |
| Rgh105B | 2808 | + | GH105 | 45.5 | rhamogalacturon hydrolase | |
| Rgh105C | 3946 | + | GH105 | 44.3 | rhamnogalacturon hydrolase | |
| Rgh105A | 951 | Lipobox | GH105 | 92.4 | rhamnogalacturon hydrolase | |
| PelG | 3881 | Lipobox | Pel | 6 | 78.2 | pectate lyase |
| PmeA | 890 | Lipobox | 75.9 | pectinesterase | ||
| Pme12A | 3094 | Lipobox | CE12 | 30.2 | pectinesterase | |
| Pel43X | 944 | Lipobox | GH43 | 42.4 | pectinesterase | |
| PmeB | 3447 | Lipobox | 115.1 | pectinesterase | ||
| Pel1D | 3448 | Lipobox | PL1 | 63.3 | pectinesterase | |
| Pel1E | 2307 | Lipobox | PL1 | 45.4 | pectate lyase | |
| Pel9A | 2946 | Lipobox | PL9 | 75.6 | exopectate lyase | |
| Pel10B | 2947 | Lipobox | PL10 | 6, 35 | 60.8 | pectate lyase |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by CAZY [11].
The xylanolytic system of S. degradans.
| Xyn10A | 181 | + | GH10 | 5, 7 | 61.7 | endoxylanase | + |
| Xyn10B | 2934 | + | GH10 | 2,10 | 65.0 | endoxylanase | + |
| Xyn10C | 2633 | + | GH10 | 92.3 | endoxylanase | + | |
| Xyn10D | 3612 | + | GH10, GH43 | 2, 6, 22 | 129.6 | endoxylanase | + |
| Xyn11A | 701 | + | GH11 | endoxylanase | + | ||
| Xyn11B | 3061 | + | GH11, CE11 | 2, 10, 60 | 80.8 | endoxylanase | + |
| Xyl43J (Arg43J) | 789 | + | GH43 | 35.1 | xylosidase | ||
| Xyl43L | 946 | + | GH43 | 36.1 | xylosidase | ||
| Gal31A | 1593 | + | GH31 | 46.5 | α-galactosidase | ||
| Glu115A | 1755 | + | GH115 | 110.0 | α-glucuronidase | ||
| Glu2G | 2632 | + | GH2 | 68.8 | β-glucuronidase | ||
| Arb51A | 1767 | + | GH51 | 59.3 | arabinofuranosidase | ||
| Arb43A | 2809 | + | GH43 | 6, 13, 35 | 85.0 | arabinofuranosidase | |
| Arb43D | 1014 | + | GH43 | 13 | 92.4 | arabitan | |
| Arg53B | 3710 | + | GH53 | 13 | 52.6 | arabinogalactan | |
| Axe2A | 2370 | + | CE2 | 40.9 | acetoxylan esterase | ||
| Gal2B | 1177 | + | GH2 | 97.1 | β-galactosidase | ||
| Gal2F | 3882 | + | GH2 | 35 | 107.1 | β-galactosidase | |
| Xyn10E | 323 | Lipobox | GH10 | 75.2 | endoxylanase | + | |
| Arb43H | 598 | Lipobox | GH43 | 63.8 | arabinofuranosidase | ||
| Arb43B | 787 | Lipobox | GH43 | 40.7 | arabinofuranosidase | ||
| Gly97C | 790 | Lipobox | GH97 | 73.3 | α-glucosidase | ||
| Arb43I | 1655 | Lipobox | GH43 | 62.6 | arabinofuranosidase | ||
| Arb43J | 791 | Lipobox | GH43 | 13 | 67.2 | arabinofuranosidase | |
| Arb43K | 822 | Lipobox | GH43 | 42.6 | xylosidase | ||
| Xyl31A | 2500 | Lipobox | GH31 | 110.2 | xylosidase | ||
| Arg53A | 683 | Lipobox | GH53 | arabinogalactan | |||
| Arg53C | 2827 | Lipobox | GH53 | Ricin | 71.1 | arabinogalactan | |
| Gly43M | 3317 | Lipobox | GH43 | 127.2 | arabinofuranosidase | ||
| Arb43E | 786 | Lipobox | GH43 | arabitan | |||
| Axe1C | 3746 | Lipobox | CE1 | 37.0 | acetoxylan esterase | ||
| Axe2C | 3143 | Lipobox | CE2 | 40.4 | acetoxylan esterase | ||
| Axe3A | 3994 | Lipobox | CE3 | 27.8 | acetoxylan esterase | ||
| Gal2A | 684 | Lipobox | GH2 | 88.1 | β-galactosidase | ||
| Gal2C | 1285 | Lipobox | GH2 | 91.8 | β-galactosidase | ||
| Gal2E | 2936 | Lipobox | GH2 | 34.0 | β-galactosidase | ||
| Gal2D | 2935 | - | GH2 | 65.6 | β-galactosidase | ||
| Arb43C | 777 | - | GH43 | 35.9 | arabinofuranosidase | ||
| Agu67A | 1025 | - | GH67 | 89.1 | α-glucuronidase | ||
| 51 | - | CE1 | 30.5 | carboxyl esterase | |||
| 2890 | - | CE1 | 30.6 | carboxyl esterase | |||
| 139 | - | CE4 | 34.3 | carboxyl esterase | |||
| 653 | - | CE4 | 41.2 | carboxyl esterase |
As described in [10];
As indicated by the presence of a Type II secretion signal or a Lipobox;
As determined by CAZY [11];
As shown by Ko et al. [56].